DK121811B - Fremgangsmåde til fremstilling af mæslingevaccine. - Google Patents

Fremgangsmåde til fremstilling af mæslingevaccine.

Info

Publication number
DK121811B
DK121811B DK605569AA DK605569A DK121811B DK 121811 B DK121811 B DK 121811B DK 605569A A DK605569A A DK 605569AA DK 605569 A DK605569 A DK 605569A DK 121811 B DK121811 B DK 121811B
Authority
DK
Denmark
Prior art keywords
producing
measles vaccine
measles
vaccine
producing measles
Prior art date
Application number
DK605569AA
Other languages
English (en)
Inventor
Ruckle G Enders
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of DK121811B publication Critical patent/DK121811B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/099Bordetella
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/155Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/165Mumps or measles virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/70Multivalent vaccine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18411Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18434Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18411Morbillivirus, e.g. Measles virus, canine distemper
    • C12N2760/18451Methods of production or purification of viral material
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK605569AA 1965-08-28 1969-11-14 Fremgangsmåde til fremstilling af mæslingevaccine. DK121811B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DEB83486A DE1247548B (de) 1965-08-28 1965-08-28 Verfahren zur Herstellung einer Masern-Vaccine

Publications (1)

Publication Number Publication Date
DK121811B true DK121811B (da) 1971-12-06

Family

ID=6981993

Family Applications (2)

Application Number Title Priority Date Filing Date
DK440366AA DK119938B (da) 1965-08-28 1966-08-29 Fremgangsmåde til fremstilling af mæslingevaccine.
DK605569AA DK121811B (da) 1965-08-28 1969-11-14 Fremgangsmåde til fremstilling af mæslingevaccine.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK440366AA DK119938B (da) 1965-08-28 1966-08-29 Fremgangsmåde til fremstilling af mæslingevaccine.

Country Status (9)

Country Link
AT (1) AT281280B (da)
BE (1) BE686101A (da)
BR (1) BR6682416D0 (da)
CH (1) CH484277A (da)
DE (1) DE1247548B (da)
DK (2) DK119938B (da)
FR (2) FR1502631A (da)
GB (1) GB1161414A (da)
NL (1) NL6611851A (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4211843A (en) * 1977-11-30 1980-07-08 L'institut Armand-Frappier Strain of measles virus and process of producing the same
CN104498446B (zh) * 2014-12-15 2017-03-15 北京科兴生物制品有限公司 一种在疫苗生产中灭活病毒的方法

Also Published As

Publication number Publication date
BE686101A (da) 1967-02-28
BR6682416D0 (pt) 1973-12-04
NL6611851A (da) 1967-03-01
CH484277A (de) 1970-01-15
GB1161414A (en) 1969-08-13
DE1247548B (de) 1967-08-17
FR1502631A (fr) 1967-11-24
FR5666M (da) 1968-01-02
DK119938B (da) 1971-03-15
AT281280B (de) 1970-05-11

Similar Documents

Publication Publication Date Title
DK128749B (da) Fremgangsmåde til forbindelse af stålstænger.
DK152134C (da) Fremgangsmaade til fremstilling af 5-azapyrimidinnukleosider
DK118769B (da) Fremgangsmåde til fremstilling af O-methyl-S-methyl-phosphoroamidothioat.
DK122997B (da) Fremgangsmåde til fremstilling af resoribletter.
DK127415B (da) Fremgangsmåde til fremstilling af α-benzyl-β,β-dialkoxypropionitriler.
DK114688B (da) Fremgangsmåde til fremstilling af 2β, 16β-diamino-3,17-oksygenerede-5α-androstaner.
DK118505B (da) Fremgangsmåde til fremstilling af isoindolin-2-sulfonylurinstoffer.
DK118239B (da) Fremgangsmåde til fremstilling af substituerede 4-hydroxykinoliner.
DK120112B (da) Fremgangsmåde til fremstilling af et geleringshjælpemiddel.
DK119627B (da) Fremgangsmåde til rensning af lipopolysaccharider.
DK115881B (da) Fremgangsmåde til fremstilling af tandstikkere.
DK138068B (da) Fremgangsmåde til fremstilling af pladeformede radiatorer.
DK113009B (da) Fremgangsmåde til stabilisering af dicalciumphosphat.
DK118732B (da) Fremgangsmåde til føring af færdige tandproteser.
DK132447B (da) Fremgangsmåde til fremstilling af kalvediarrevirusvaccine.
DK128470B (da) Fremgangsmåde til fremstilling af varmelegemer.
DK126223B (da) Fremgangsmåde til fremstilling af græstørv.
DK119938B (da) Fremgangsmåde til fremstilling af mæslingevaccine.
DK122008B (da) Fremgangsmåde til fremstilling af bakteriefraktioner.
DK127902B (da) Fremgangsmåde til fremstilling af plantesokler.
DK112606B (da) Fremgangsmåde til rensning af insulin.
DK121619B (da) Fremgangsmåde til fremstilling af en vaccine mod rubella.
DK118458B (da) Fremgangsmåde til fremstilling af 5-halogen-2-amino-benzophenoniminer.
DK118670B (da) Fremgangsmåde til fremstilling af cyanphenoler.
DK128279B (da) Fremgangsmåde til fremstilling af α,ω-alkylendiaminer.